|
|
positive regulation of immature t cell proliferation
|
GO:0033091 |
4 |
1.000
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
1.000
|
Human |
|
|
histone modification
|
GO:0016570 |
159 |
1.000
|
Human |
|
|
histone h2a monoubiquitination
|
GO:0035518 |
1 |
1.000
|
Human |
|
|
chromatin modification
|
GO:0016568 |
187 |
0.999
|
Human |
|
|
dna methylation
|
GO:0006306 |
43 |
0.999
|
|
|
|
histone h2a ubiquitination
|
GO:0033522 |
3 |
0.999
|
Human |
|
|
dna alkylation
|
GO:0006305 |
43 |
0.999
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.998
|
|
|
|
rostrocaudal neural tube patterning
|
GO:0021903 |
12 |
0.997
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.996
|
|
|
|
cell cycle comprising mitosis without cytokinesis
|
GO:0033301 |
1 |
0.995
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.995
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.993
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.992
|
|
|
|
positive regulation of b cell proliferation
|
GO:0030890 |
24 |
0.991
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.990
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.989
|
Human |
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.985
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.984
|
|
|
|
immature t cell proliferation
|
GO:0033079 |
8 |
0.982
|
|
|
|
histone ubiquitination
|
GO:0016574 |
10 |
0.979
|
Human |
|
|
positive regulation of immature t cell proliferation in thymus
|
GO:0033092 |
3 |
0.978
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.978
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.977
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.977
|
|
|
|
regulation of t cell differentiation in thymus
|
GO:0033081 |
24 |
0.977
|
|
|
|
dna modification
|
GO:0006304 |
50 |
0.976
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.971
|
Human |
|
|
neural tube patterning
|
GO:0021532 |
43 |
0.966
|
|
|
|
histone monoubiquitination
|
GO:0010390 |
3 |
0.965
|
Human |
|
|
regulation of b cell proliferation
|
GO:0030888 |
39 |
0.956
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.956
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.952
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.940
|
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.939
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.939
|
|
|
|
positive regulation of t cell differentiation in thymus
|
GO:0033089 |
13 |
0.933
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.927
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.927
|
|
|
|
positive regulation of t cell differentiation
|
GO:0045582 |
52 |
0.924
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.921
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.912
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.905
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.904
|
|
|
|
chromatin silencing
|
GO:0006342 |
15 |
0.896
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.896
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.893
|
Human |
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.891
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.889
|
Human |
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.882
|
|
|
|
positive regulation of lymphocyte differentiation
|
GO:0045621 |
61 |
0.879
|
|
|
|
positive regulation of b cell activation
|
GO:0050871 |
49 |
0.878
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.864
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.864
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.859
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.858
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.834
|
|
|
|
positive regulation of t cell proliferation
|
GO:0042102 |
52 |
0.825
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.821
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.807
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.804
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.799
|
|
|
|
regulation of immature t cell proliferation in thymus
|
GO:0033084 |
6 |
0.797
|
|
|
|
mitotic cell cycle embryonic
|
GO:0045448 |
5 |
0.796
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.788
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.787
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.787
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.787
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.785
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.784
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.782
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.760
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.758
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.754
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.743
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.722
|
|
|
|
immature t cell proliferation in thymus
|
GO:0033080 |
7 |
0.700
|
|
|
|
negative regulation of gene expression epigenetic
|
GO:0045814 |
15 |
0.670
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.668
|
|
|
|
stem cell division
|
GO:0017145 |
30 |
0.645
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.643
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.606
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.576
|
|
|
|
protein monoubiquitination
|
GO:0006513 |
11 |
0.571
|
Human |
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.567
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.558
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.553
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.545
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.533
|
|
|
|
trunk segmentation
|
GO:0035290 |
4 |
0.529
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.517
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
42 |
0.494
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.432
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.419
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.390
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.386
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.381
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.349
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.337
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.332
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.328
|
|
|
|
response to hydrogen peroxide
|
GO:0042542 |
32 |
0.324
|
|
|
|
regulation of immature t cell proliferation
|
GO:0033083 |
7 |
0.307
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.291
|
|
|
|
somatic stem cell division
|
GO:0048103 |
19 |
0.248
|
|
|
|
segment specification
|
GO:0007379 |
15 |
0.245
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.219
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.204
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.196
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.188
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.185
|
|
|
|
regulation of dna methylation
|
GO:0044030 |
12 |
0.182
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.180
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.178
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.170
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.165
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.152
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.145
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.143
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.143
|
|
|
|
sebaceous gland development
|
GO:0048733 |
7 |
0.142
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.141
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.131
|
|
|
|
transdifferentiation
|
GO:0060290 |
1 |
0.126
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.126
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.125
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.120
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.118
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.118
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.112
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.112
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.112
|
|
|
|
negative regulation of intrinsic apoptotic signaling pathway
|
GO:2001243 |
34 |
0.110
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.108
|
|
|
|
blastocyst growth
|
GO:0001832 |
23 |
0.105
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.104
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.103
|
|
|
|
sister chromatid cohesion
|
GO:0007062 |
12 |
0.102
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.101
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.101
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.101
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.101
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.098
|
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.097
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.094
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.090
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.088
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.085
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.085
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.084
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.083
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.083
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.083
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.083
|
|
|
|
regulation of chromatin silencing
|
GO:0031935 |
2 |
0.082
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.082
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.080
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.079
|
|
|
|
negative regulation of posttranscriptional gene silencing
|
GO:0060149 |
1 |
0.077
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.077
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.074
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.073
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.073
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.071
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.070
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.068
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.067
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.066
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.066
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.065
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.064
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.063
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.063
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.062
|
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.062
|
|
|
|
myelination in peripheral nervous system
|
GO:0022011 |
19 |
0.062
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.061
|
|
|
|
chromatin remodeling
|
GO:0006338 |
32 |
0.061
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.061
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.061
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.060
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.060
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.060
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.059
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.059
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.059
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.059
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.058
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.057
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.056
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.056
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.055
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.055
|
|
|
|
b cell mediated immunity
|
GO:0019724 |
71 |
0.054
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.054
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.054
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.053
|
|
|
|
mrna transcription from rna polymerase ii promoter
|
GO:0042789 |
4 |
0.053
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.053
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.053
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.053
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.053
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.052
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.052
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.051
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.051
|
|
|
|
cranial nerve development
|
GO:0021545 |
41 |
0.051
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.051
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.051
|
|
|
|
regulation of histone h3 k4 methylation
|
GO:0051569 |
12 |
0.050
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.050
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.050
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.050
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.049
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.049
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.049
|
|
|
|
protein deacylation
|
GO:0035601 |
36 |
0.048
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.048
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.048
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.048
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.048
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.048
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.047
|
|
|
|
midbrain hindbrain boundary morphogenesis
|
GO:0021555 |
4 |
0.047
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.046
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.046
|
|
|
|
negative regulation of cardiac chamber morphogenesis
|
GO:1901220 |
2 |
0.045
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.045
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.045
|
|
|
|
regulation of smoothened signaling pathway
|
GO:0008589 |
58 |
0.045
|
|
|
|
heterochromatin organization
|
GO:0070828 |
4 |
0.044
|
|
|
|
macromolecule deacylation
|
GO:0098732 |
37 |
0.044
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.044
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.043
|
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.043
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.043
|
|
|
|
habituation
|
GO:0046959 |
3 |
0.043
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.043
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.043
|
|
|
|
neuron maturation
|
GO:0042551 |
29 |
0.043
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.043
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.042
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.042
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.042
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.042
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.042
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.042
|
|
|
|
somatic diversification of immune receptors
|
GO:0002200 |
53 |
0.041
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.041
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.041
|
|
|
|
nerve development
|
GO:0021675 |
67 |
0.041
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.041
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.040
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.040
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.040
|
|
|
|
visceral motor neuron differentiation
|
GO:0021524 |
3 |
0.040
|
|
|
|
hippo signaling
|
GO:0035329 |
11 |
0.040
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.040
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.040
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.040
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.039
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.039
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.039
|
|
|
|
forebrain neuron fate commitment
|
GO:0021877 |
13 |
0.039
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.039
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.039
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.039
|
|
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
61 |
0.039
|
|
|
|
negative regulation of canonical wnt signaling pathway involved in neural plate anterior posterior pattern formation
|
GO:0060829 |
1 |
0.038
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.038
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.038
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.038
|
|
|
|
histone h3 k36 demethylation
|
GO:0070544 |
2 |
0.038
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.038
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
28 |
0.038
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.038
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.038
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.038
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.038
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.037
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.037
|
|
|
|
trophectodermal cell differentiation
|
GO:0001829 |
21 |
0.037
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.037
|
|
|
|
sinoatrial node cell differentiation
|
GO:0060921 |
3 |
0.037
|
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.037
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.037
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.037
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.037
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.037
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.036
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.036
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.036
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.036
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.036
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
29 |
0.036
|
|
|
|
middle ear morphogenesis
|
GO:0042474 |
23 |
0.036
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.035
|
|
|
|
vagus nerve morphogenesis
|
GO:0021644 |
2 |
0.035
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.035
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.035
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.034
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.034
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.034
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.034
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.033
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.033
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.033
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.033
|
|
|
|
preganglionic parasympathetic nervous system development
|
GO:0021783 |
17 |
0.033
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.033
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.033
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.033
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.032
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.032
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.032
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.032
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.032
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.032
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.032
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.031
|
|
|
|
cellular response to retinoic acid
|
GO:0071300 |
25 |
0.031
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.031
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.031
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.031
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.031
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.031
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.031
|
|
|
|
smad protein complex assembly
|
GO:0007183 |
1 |
0.031
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.031
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.031
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.031
|
|
|
|
intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:0072332 |
35 |
0.031
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.030
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.030
|
|
|
|
dna templated transcription termination
|
GO:0006353 |
4 |
0.030
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.030
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.030
|
|
|
|
bundle of his development
|
GO:0003166 |
4 |
0.029
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.029
|
|
|
|
protein deacetylation
|
GO:0006476 |
32 |
0.029
|
|
|
|
thick ascending limb development
|
GO:0072023 |
2 |
0.029
|
|
|
|
schwann cell development
|
GO:0014044 |
22 |
0.029
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.029
|
|
|
|
isotype switching
|
GO:0045190 |
36 |
0.029
|
|
|
|
somatotropin secreting cell development
|
GO:0060133 |
2 |
0.029
|
|
|
|
metanephric ascending thin limb development
|
GO:0072218 |
2 |
0.028
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.028
|
Fly |
|
|
regulation of dna recombination
|
GO:0000018 |
34 |
0.028
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.028
|
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.028
|
|
|
|
immunoglobulin production involved in immunoglobulin mediated immune response
|
GO:0002381 |
43 |
0.028
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.027
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.027
|
|
|
|
double strand break repair
|
GO:0006302 |
48 |
0.027
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.027
|
|
|
|
schwann cell differentiation
|
GO:0014037 |
26 |
0.027
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.027
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.027
|
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
43 |
0.027
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.027
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.027
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.027
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.027
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.027
|
|
|
|
response to ketone
|
GO:1901654 |
15 |
0.026
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.026
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.026
|
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.026
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.026
|
|
|
|
positive regulation of skeletal muscle fiber differentiation
|
GO:1902811 |
2 |
0.026
|
|
|
|
positive regulation of megakaryocyte differentiation
|
GO:0045654 |
4 |
0.026
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.026
|
|
|
|
gastrulation with mouth forming second
|
GO:0001702 |
29 |
0.026
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.026
|
|
|
|
mammary placode formation
|
GO:0060596 |
4 |
0.026
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.026
|
|
|
|
enamel mineralization
|
GO:0070166 |
7 |
0.026
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.025
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.025
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation
|
GO:0003257 |
3 |
0.025
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.025
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.025
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.025
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.025
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.025
|
|
|
|
commitment of neuronal cell to specific neuron type in forebrain
|
GO:0021902 |
7 |
0.025
|
|
|
|
synaptonemal complex assembly
|
GO:0007130 |
13 |
0.025
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.025
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.025
|
|
|
|
histone h3 k9 methylation
|
GO:0051567 |
17 |
0.025
|
|
|
|
histone lysine demethylation
|
GO:0070076 |
13 |
0.025
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.024
|
|
|
|
ectodermal cell differentiation
|
GO:0010668 |
3 |
0.024
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in heart development
|
GO:1901228 |
4 |
0.024
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
31 |
0.024
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.024
|
|
|
|
embryonic camera type eye development
|
GO:0031076 |
36 |
0.024
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.024
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.024
|
|
|
|
genetic imprinting
|
GO:0071514 |
27 |
0.024
|
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.024
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.024
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.024
|
|
|
|
dna hypermethylation
|
GO:0044026 |
3 |
0.024
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.023
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.023
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.023
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.023
|
|
|
|
positive regulation of lymphocyte mediated immunity
|
GO:0002708 |
62 |
0.023
|
|
|
|
regulation of tongue muscle cell differentiation
|
GO:2001035 |
2 |
0.023
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.023
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.023
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.023
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.023
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.023
|
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.023
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.022
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.022
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.022
|
Fly |
|
|
nucleosome positioning
|
GO:0016584 |
4 |
0.022
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
57 |
0.022
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.022
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.022
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.022
|
|
|
|
photoreceptor cell development
|
GO:0042461 |
40 |
0.022
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.022
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.022
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.022
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.022
|
|
|
|
somatic diversification of immunoglobulins involved in immune response
|
GO:0002208 |
36 |
0.022
|
|
|
|
his purkinje system cell differentiation
|
GO:0060932 |
2 |
0.022
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.022
|
|
|
|
epithalamus development
|
GO:0021538 |
2 |
0.022
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.022
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.022
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.021
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.021
|
|
|
|
embryonic hemopoiesis
|
GO:0035162 |
23 |
0.021
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.021
|
|
|
|
mesodermal to mesenchymal transition involved in gastrulation
|
GO:0060809 |
1 |
0.021
|
|
|
|
his purkinje system development
|
GO:0003164 |
4 |
0.021
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.021
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.021
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.021
|
|
|
|
positive regulation of leukocyte mediated immunity
|
GO:0002705 |
70 |
0.021
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.021
|
|
|
|
positive regulation of myotube differentiation
|
GO:0010831 |
24 |
0.021
|
|
|
|
somatic cell dna recombination
|
GO:0016444 |
51 |
0.021
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.021
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.021
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.021
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.021
|
|
|
|
neuron remodeling
|
GO:0016322 |
7 |
0.020
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.020
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.020
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.020
|
|
|
|
fourth ventricle development
|
GO:0021592 |
2 |
0.020
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.020
|
|
|
|
tongue muscle cell differentiation
|
GO:0035981 |
2 |
0.020
|
|
|
|
endocardial cushion formation
|
GO:0003272 |
13 |
0.020
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.020
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.020
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.020
|
|
|
|
inner cell mass cell fate commitment
|
GO:0001827 |
2 |
0.019
|
|
|
|
regulation of hippo signaling
|
GO:0035330 |
1 |
0.019
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.019
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.019
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.019
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.019
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.019
|
|
|
|
somatic diversification of immune receptors via germline recombination within a single locus
|
GO:0002562 |
51 |
0.019
|
|
|
|
vagus nerve development
|
GO:0021564 |
3 |
0.019
|
|
|
|
regulation of chondrocyte differentiation
|
GO:0032330 |
33 |
0.019
|
|
|
|
habenula development
|
GO:0021986 |
2 |
0.019
|
|
|
|
histone deacetylation
|
GO:0016575 |
26 |
0.019
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.019
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.019
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.019
|
|
|
|
b cell activation involved in immune response
|
GO:0002312 |
50 |
0.019
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.019
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.019
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.019
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.019
|
|
|
|
chondrocyte hypertrophy
|
GO:0003415 |
4 |
0.019
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.019
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.019
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.019
|
|
|
|
regulation of cardiac chamber morphogenesis
|
GO:1901219 |
2 |
0.018
|
|
|
|
midbrain hindbrain boundary development
|
GO:0030917 |
9 |
0.018
|
|
|
|
metanephric thick ascending limb development
|
GO:0072233 |
2 |
0.018
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.018
|
|
